North Shore-LIJ

Modulate the Dose

CBS New York reports that pharmacogenomic testing can explain why some patients do not get relief from certain treatments.

The two entities also plan to work together using the data generated from the tests to do added research.

It will be the first comprehensive clinical-oriented collaboration for CSHL, and is expected to enable the institution to more quickly move its basic biomarker and therapeutic discoveries to the clinic.

Cold Spring Harbor Laboratory partners with the North Shore-LIJ Health System to pursue cancer therapeutics research.

Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.

Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.

In Science this week: research regulation and reporting requirement reform, and more.

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.